Description
Prostaglandin E2 production by intestinal cells under inflammatory conditions is attenuated by butyrate, as measured by ELISA across multiple treatment concentrations.
More Figures from This Paper
Figure 1
NF-κB signaling pathway activation in intestinal cells is measured with and without butyrate pre-treatment following LPS challenge, demonstrating the short-chain fatty acid's inhibitory capacity.
chart
Figure 3
Gene expression profiles for inflammatory mediators in LPS-stimulated intestinal cells are compared across varying butyrate concentrations, revealing a clear anti-inflammatory dose response.
chart
Figure 4
Cell viability assays confirm that butyrate concentrations used in the inflammation experiments are non-cytotoxic, validating the specificity of observed anti-inflammatory effects.
chart
Figure 5
Transepithelial electrical resistance measurements across intestinal cell monolayers demonstrate butyrate's capacity to maintain epithelial integrity during inflammatory challenge.
chart
Figure 6
Western blot analysis of phosphorylated signaling proteins in LPS-treated intestinal cells shows reduced inflammatory cascade activation in the presence of butyrate.
Figure 7
Cytokine secretion profiles including IL-6, IL-8, and TNF-α are quantified in cell culture supernatants, with butyrate-treated cells showing significantly attenuated inflammatory responses.
chartFigure 10
ChartSource Paper
Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.Cite This Figure
 > Source: Ilaria Russo et al. "Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells ." *PloS one*, 2012. PMID: [22412931](https://pubmed.ncbi.nlm.nih.gov/22412931/)
<figure> <img src="https://pdfs.citedhealth.com/figures/22412931/145.png" alt="Prostaglandin E2 production by intestinal cells under inflammatory conditions is attenuated by butyrate, as measured by ELISA across multiple treatment concentrations." /> <figcaption>Figure 10. Prostaglandin E2 production by intestinal cells under inflammatory conditions is attenuated by butyrate, as measured by ELISA across multiple treatment concentrations.<br> Source: Ilaria Russo et al. "Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells ." <em>PloS one</em>, 2012. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/22412931/">22412931</a></figcaption> </figure>